The ERalpha coactivator, HER4/4ICD, regulates progesterone receptor expression in normal and malignant breast epithelium
about
Interactions of ErbB4 and Kap1 connect the growth factor and DNA damage response pathwaysReceptor tyrosine kinases in the nucleusThe localization of HER4 intracellular domain and expression of its alternately-spliced isoforms have prognostic significance in ER+ HER2- breast cancer.Estrogen receptor, progesterone receptor, interleukin-6 and interleukin-8 are variable in breast cancer and benign stem/progenitor cell populations.Estrogen receptor coregulators and pioneer factors: the orchestrators of mammary gland cell fate and development.The prognostic value of Her4 receptor isoform expression in triple-negative and Her2 positive breast cancer patients.Thyroid hormone status interferes with estrogen target gene expression in breast cancer samples in menopausal women.Multiple Functional Motifs Are Required for the Tumor Suppressor Activity of a Constitutively-Active ErbB4 Mutant.Endocrine resistance in breast cancer: molecular pathways and rational development of targeted therapies.ERBB4 Expression in Ovarian Serous Carcinoma Resistant to Platinum-Based Therapy.HER4 selectively coregulates estrogen stimulated genes associated with breast tumor cell proliferation.Direct coupling of the HER4 intracellular domain (4ICD) and STAT5A signaling is required to induce mammary epithelial cell differentiation.Association of ErbB1-4 expression in invasive breast cancer with clinicopathological characteristics and prognosis.Subtyping Of Triple Negative Breast Carcinoma On The Basis Of RTK Expression
P2860
Q24300478-D9342426-53BB-4CC8-9DF7-5879DDA41C15Q26830216-E400573C-50BE-4167-B478-B798106435E8Q33977133-8FB14A5C-0EA4-4448-8CA5-50FD350D29B9Q34309582-380D00B4-3F38-4184-A9B1-F51237EFC3B3Q34391427-376CD229-C9C9-4ADA-962B-C20ABD5B643DQ34996222-E78CD2A9-D732-4939-986B-9064B5210F9BQ37631648-54D2BD25-5558-47AB-BE9D-11C8CD92DEE0Q37727542-2EE4D64A-E1B9-4D11-848F-1DEBDF3656B5Q37992693-6661242D-F288-47DF-92A3-36D0C4588A5EQ38971615-25BEE6DF-A679-48F0-98AE-A9C7A6BD249CQ39044090-508BE5BF-E333-4409-80B4-1B3087F0A767Q41682816-05243FE4-C15D-478A-9A6E-57B3D9A9C430Q54286036-A4C5D0EF-4C9B-49C5-8CBB-9DBD1015700BQ56968081-D1832E76-4826-424B-93B6-067BACB9D0B5
P2860
The ERalpha coactivator, HER4/4ICD, regulates progesterone receptor expression in normal and malignant breast epithelium
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The ERalpha coactivator, HER4/ ...... nd malignant breast epithelium
@ast
The ERalpha coactivator, HER4/ ...... nd malignant breast epithelium
@en
type
label
The ERalpha coactivator, HER4/ ...... nd malignant breast epithelium
@ast
The ERalpha coactivator, HER4/ ...... nd malignant breast epithelium
@en
prefLabel
The ERalpha coactivator, HER4/ ...... nd malignant breast epithelium
@ast
The ERalpha coactivator, HER4/ ...... nd malignant breast epithelium
@en
P2093
P2860
P356
P1433
P1476
The ERalpha coactivator, HER4/ ...... nd malignant breast epithelium
@en
P2093
Beatrice A Howard
David L Rimm
Frank E Jones
Jennifer M Giltnane
Jerzy Rokicki
Olivia Wansbury
Partha M Das
P2860
P2888
P356
10.1186/1476-4598-9-150
P577
2010-06-15T00:00:00Z
P5875
P6179
1047470796